Advanced Nuclear Medicine for Accurate Cancer Diagnosis

Nuclear Medicine

The Department of Nuclear Medicine at Thangam Hospital offers cutting-edge diagnostic imaging and targeted radionuclide therapies, combining precision diagnosis with advanced treatment options. Equipped with state-of-the-art facilities, our team delivers personalized, safe, and effective care for cancer and other complex conditions.

Facilities

PET-CT Scanner – High-resolution metabolic imaging for oncology, neurology, cardiology, and infection-related disorders.
Gamma Camera / SPECT-CT – Advanced functional imaging for organ-specific studies.
Radionuclide Therapy Ward – Dedicated and safe setup for targeted radioisotope therapies.

PET-CT scan (Positron Emission Tomography – Computed Tomography)

PET-CT combines functional and anatomical imaging, using a small radioactive tracer that accumulates in areas of high metabolic activity such as cancer cells, infections, or inflammation.

Types of PET-CT scans available at Thangam Hospital:

18F-FDG PET Scan – Daily scans for detecting, staging, and monitoring various cancers; also valuable in brain, cardiac, and infection imaging.

PSMA PET Scan – Highly sensitive imaging for prostate cancer, enabling detection of small metastases, guiding surgical and radiation planning, and monitoring treatment response.

Applications of PET-CT:

Early cancer detection and staging
Monitoring treatment effectiveness
Identifying recurrence or residual disease
Evaluating brain disorders (tumors, Alzheimer’s, epilepsy)
Assessing cardiac viability and perfusion
Locating hidden infections or inflammatory foci

SPECT-CT / Gamma Camera Imaging

With advanced Gamma Camera and SPECT-CT technology, our Nuclear Medicine Department provides functional diagnosis for renal, cardiac, skeletal, endocrine, pulmonary, and gastrointestinal conditions.

Services offered:

Renal Imaging: 99mTc DTPA/LLEC Renogram, 99mTc DMSA renal cortical scan
Hepatobiliary & GI Imaging: 99mTc HIDA scan, 99mTc Sulfur colloid reflux study, RBC scintigraphy for GI bleed, Meckel’s scan
Endocrine Imaging: 99mTc Thyroid scan, 99mTc MIBI parathyroid scintigraphy
Cardiac Imaging: 99mTc MIBI myocardial perfusion imaging
Pulmonary Imaging: 99mTc MAA lung perfusion studies
Skeletal Imaging: 99mTc MDP bone scan, lymphoscintigraphy for sentinel lymph node mapping

Radionuclide Therapy (Theranostics)

Beyond diagnosis, the Department of Nuclear Medicine offers theranostics—a dual approach that combines targeted therapy with diagnostic imaging for highly personalized cancer care.

Therapies offered include:

Radioiodine Therapy – For hyperthyroidism and differentiated thyroid cancer
PRRT (Peptide Receptor Radionuclide Therapy) – Targeted treatment for neuroendocrine tumors (NETs)
Lu-PSMA Therapy – Advanced radionuclide therapy for prostate cancer